University of Alberta Sues AMDL Over Technology Transfer
The University of Alberta sued California-based pharmaceutical company AMDL in Alberta over patents involved in combination immunogene therapy (CIT), AMDL said in a form 8-K filed with the Securities and Exchange...To view the full article, register now.
Already a subscriber? Click here to view full article